| Product Code: ETC8253515 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market - Industry Life Cycle |
3.4 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market - Porter's Five Forces |
3.5 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Mauritius leading to higher chemotherapy usage |
4.2.2 Advancements in chemotherapy treatments leading to higher incidence of chemotherapy-induced peripheral neuropathy |
4.2.3 Growing awareness among healthcare professionals about the management of chemotherapy-induced peripheral neuropathy |
4.3 Market Restraints |
4.3.1 High cost associated with neuropathy treatment and management |
4.3.2 Limited availability of specialized healthcare professionals for neuropathy treatment in Mauritius |
5 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Trends |
6 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market, By Types |
6.1 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.4 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.5 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Anti-Seizure, 2021- 2031F |
6.1.6 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Narcotics, 2021- 2031F |
6.2 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.2.3 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.4 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Import-Export Trade Statistics |
7.1 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Export to Major Countries |
7.2 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Imports from Major Countries |
8 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Key Performance Indicators |
8.1 Number of new chemotherapy-induced peripheral neuropathy cases diagnosed annually in Mauritius |
8.2 Percentage of healthcare professionals in Mauritius trained in managing chemotherapy-induced peripheral neuropathy |
8.3 Patient satisfaction scores with neuropathy treatment and support services in Mauritius |
9 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market - Opportunity Assessment |
9.1 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market - Competitive Landscape |
10.1 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Chemotherapy-Induced Peripheral Neuropathy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here